Potent Cytotoxicity and Nitric Oxide Suppression of Compounds Derived from Kaempferia elegans Rhizomes: Molecular Modeling on EGFR Inhibition
Issued Date
2024-09-01
Resource Type
ISSN
13076167
Scopus ID
2-s2.0-85208435129
Journal Title
Records of Natural Products
Volume
18
Issue
5
Start Page
514
End Page
519
Rights Holder(s)
SCOPUS
Bibliographic Citation
Records of Natural Products Vol.18 No.5 (2024) , 514-519
Suggested Citation
Savaspun K., Thepmalee C., Myo H., Arinno A., Phanumartwiwath A., Aongbangkhen C., Eurtivong C., Boonchaisri S., Ninjiaranai P., Sam-Ang P. Potent Cytotoxicity and Nitric Oxide Suppression of Compounds Derived from Kaempferia elegans Rhizomes: Molecular Modeling on EGFR Inhibition. Records of Natural Products Vol.18 No.5 (2024) , 514-519. 519. doi:10.25135/rnp.472.2406.3250 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/102026
Title
Potent Cytotoxicity and Nitric Oxide Suppression of Compounds Derived from Kaempferia elegans Rhizomes: Molecular Modeling on EGFR Inhibition
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
A new naturally occurring diarylheptanoid, (1E,4Z,6E)-5-hydroxy-1,7-diphenylhepta-1,4,6-trien-3-one (3), was isolated from the rhizomes of K. elegans along with six known compounds, flavokawain B (1), 5,6-dehydrokawain (2), pinocembrin (4), cardamonin (5), alpinetin (6), and crotepoxide (7), among which compound 6 had not previously been isolated from this plant species. Two chalcones, flavokawain B (1) and cardamonin (5) were active against nitric oxide (NO) radicals released from LPS-induced RAW264.7 macrophages, resulting in 91.58% and 98.68% inhibition of NO production, respectively. Furthermore, compounds 1 and 5 showed superior cytotoxicity against MCF-7 (IC50 = 23.07 and 20.84 µM) and MDA-MB-231 (IC50 = 21.77 and 26.64 µM) cell lines, respectively. In silico molecular modeling studies of the most active compounds 1 and 5 against epidermal growth factor receptors (EGFR) suggested that π–π interactions with residues on the EGFR protein contributed to their anticancer properties. The results suggest that cardamonin (5) could be a promising candidate for further development of anti-inflammatory and anticancer agents.